Özlem Atlı Eklioğlu (Y Özkay, Yusuf Özkay, Yusuf Ozkay)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Molecular Docking

Antimicrobial Resistance

Early Breast Cancer

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Archiv der Pharmazie

Current microbiology

SAR and QSAR in environmental research

This page only lists publications with an associated author ORCID identifier.

Publications

Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmani Ye, Özlem Atlı Eklioğlu, Fatih Demirci
Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current microbiology 81 (8) (2024)
Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmani Ye, Özlem Atlı Eklioğlu, Fatih Demirci
Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current microbiology 81 (8) (2024)
Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmani Ye, Özlem Atlı Eklioğlu, Fatih Demirci
Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current microbiology 81 (8) (2024)
Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmani Ye, Özlem Atlı Eklioğlu, Fatih Demirci
Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current microbiology 81 (8) (2024)
Tuncay Söylemez, Zafer Asım Kaplancıklı, Derya Osmani Ye, Özlem Atlı Eklioğlu, Fatih Demirci
Selective in vitro Synergistic Evaluation of Probiotic Tolerant morpholinyl- and 4-ethylpiperazinyl-Imidazole-chalcone Derivatives on Gastrointestinal System Pathogens. Current microbiology 81 (8) (2024)
Ulviye Acar Çevik, Ismail Celik, Leyla Paşayeva, Hanifa Fatullayev, Hayrani E Bostancı, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents. Archiv der Pharmazie (2023)
Ulviye Acar Çevik, A Işık, Asaf Evrim Evren, Ö Kapusız, Ü D Gül, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies. SAR and QSAR in environmental research 33 (11) (2022)
Derya Osmani Ye, Iqrar Ahmad Ansari, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Harun M Patel, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis and molecular docking and ADME studies of novel hydrazone derivatives for AChE inhibitory, BBB permeability and antioxidant effects. Journal of biomolecular structure & dynamics (2022)
A Işık, Ulviye Acar Çevik, A Karayel, İsmail Çelik, T Erçetin, A Koçak, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities. SAR and QSAR in environmental research 33 (3) (2022)
Derya Osmani Ye, Cüneyt Türkeş, Malihe Moradzadeh, Özlem Atlı Eklioğlu, Şükrü Beydemir, Zafer Asım Kaplancıklı
Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors. Archiv der Pharmazie 355 (8) (2022)
Şevval Karaca, Derya Osmani Ye, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Sinem Ilgın, Özlem Atlı Eklioğlu, Ahmet Çağrı Karaburun, Zafer Asım Kaplancıklı, Nalan Gundogdu-Karaburun
Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease. RSC advances 12 (36) (2022)
Sazan Haji Ali, Derya Osmani Ye, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, Synthesis, and Evaluation of Novel 2 H -Benzo[b][1,4]thiazin-3(4 H )-one Derivatives as New Acetylcholinesterase Inhibitors. Molecules (Basel, Switzerland) 27 (7) (2022)
Ulviye Acar Çevik, İsmail Çelik, Ayşen Işık, Iqrar Ahmad Ansari, Harun M Patel, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors. Journal of biomolecular structure & dynamics (2022)
Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Ali Savaş Koparal, Zafer Asım Kaplancıklı
Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Derya Osmani Ye, Berkant Kurban, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors. Molecules (Basel, Switzerland) 26 (21) (2021)
Derya Osmani Ye, Asaf E Evren, Begüm N Sağlık, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors. Archiv der Pharmazie 355 (3) (2021)
İlçim Ceyhun, Şevval Karaca, Derya Osmani Ye, Begüm Nurpelin Sağlık Özkan, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase. Archiv der Pharmazie (2021)
Ulviye Acar Çevik, Begüm Nurpelin Sağlık Özkan, Derya Osmani Ye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah Burak Karaduman, Ozlem Atli-Eklioglu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık Özkan, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors. Archiv der Pharmazie 354 (3) (2020)
Begüm Nurpelin Sağlık Özkan, Betül Kaya Çavuşoğlu, Ulviye Acar Çevik, Derya Osmani Ye, Serkan Levent, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling. RSC medicinal chemistry 11 (9) (2020)
Begüm Nurpelin Sağlık Özkan, Derya Osmaniye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease. Molecules (Basel, Switzerland) 25 (18) (2020)
Begüm Nurpelin Sağlık Özkan, Osman Cebeci, Ulviye Acar Çevik, Derya Osmaniye, Serkan Levent, Betül Kaya Çavuşoğlu, Sinem Ilgın, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors. Molecules (Basel, Switzerland) 25 (18) (2020)
Ulviye Acar Çevik, Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık, Derya Osmaniye, Serkan Levent, Sinem Ilgın, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor. Molecules (Basel, Switzerland) 25 (7) (2020)
Ulviye Acar Çevik, Begüm N Sağlık, Derya Osmaniye, Serkan Levent, Betül Kaya Çavuşoğlu, Abdullah B Karaduman, Özlem Atlı Eklioğlu, Zafer A Kaplancıklı
Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors. Archiv der Pharmazie 353 (5) (2020)
Derya Osmaniye, Begüm Nurpelin Sağlık, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı, Gülhan Turan
Synthesis and AChE Inhibitory Activity of Novel Thiazolylhydrazone Derivatives. Molecules (Basel, Switzerland) 24 (13) (2019)
Ahmet Çağrı Karaburun, Betül Kaya Çavuşoğlu, Ulviye Acar Çevik, Derya Osmaniye, Begüm Nurpelin Sağlık, Serkan Levent, Özlem Atlı Eklioğlu, Özlem Atlı, Ali Savaş Koparal, Zafer Asım Kaplancıklı
Synthesis and Antifungal Potential of Some Novel Benzimidazole-1,3,4-Oxadiazole Compounds. Molecules (Basel, Switzerland) 24 (1) (2019)
Ulviye Acar Cevik, Begüm Nurpelin Saglik, Serkan Levent, Derya Osmaniye, Betul Kaya Cavuşoglu, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives. Molecules (Basel, Switzerland) 24 (5) (2019)
Derya Osmaniye, Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık, Serkan Levent, Ulviye Acar Çevik, Özlem Atlı, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis and Anticandidal Activity of New Imidazole-Chalcones. Molecules (Basel, Switzerland) 23 (4) (2018)
Weiam Hussein, Begüm Nurpelin Sağlık, Serkan Levent, Büşra Korkut, Sinem Ilgın, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease. Molecules (Basel, Switzerland) 23 (8) (2018)
Derya Osmaniye, Serkan Levent, Abdullah Burak Karaduman, Sinem Ilgın, Özlem Atlı Eklioğlu, Zafer Asım Kaplancıklı
Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents. Molecules (Basel, Switzerland) 23 (5) (2018)